Yang W - Search Results

1

Correction: HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer.

Li A, Liu Z, Li M, Zhou S, Xu Y, Xiao Y, Yang W. Li A, et al. Among authors: yang w. Oncotarget. 2017 May 2;8(18):30619-30620. doi: 10.18632/oncotarget.17542. Oncotarget. 2017. PMID: 28472784 Free PMC article. No abstract available.

2

Invasive breast carcinomas of no special type with osteoclast-like giant cells frequently have a luminal phenotype.

Zhou S, Yu L, Zhou R, Li X, Yang W. Zhou S, et al. Among authors: yang w. Virchows Arch. 2014 Jun;464(6):681-8. doi: 10.1007/s00428-014-1573-y. Epub 2014 Apr 13. Virchows Arch. 2014. PMID: 24728734

3

HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer.

Li A, Liu Z, Li M, Zhou S, Xu Y, Xiao Y, Yang W. Li A, et al. Among authors: yang w. Oncotarget. 2016 Jun 21;7(25):37966-37978. doi: 10.18632/oncotarget.9274. Oncotarget. 2016. PMID: 27177225 Free PMC article.

4

Low frequency of BRAF and KRAS mutations in Chinese patients with low-grade serous carcinoma of the ovary.

Xu Y, Bi R, Xiao Y, Tu X, Li M, Li A, Shan L, Zhou S, Yang W. Xu Y, et al. Among authors: yang w. Diagn Pathol. 2017 Dec 22;12(1):87. doi: 10.1186/s13000-017-0679-3. Diagn Pathol. 2017. PMID: 29273082 Free PMC article.

5

Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer.

Li M, Li A, Zhou S, Xu Y, Xiao Y, Bi R, Yang W. Li M, et al. Among authors: yang w. BMC Cancer. 2018 Jan 2;18(1):4. doi: 10.1186/s12885-017-3916-y. BMC Cancer. 2018. PMID: 29291717 Free PMC article.

6

Differential expression and clinical significance of epithelial-mesenchymal transition markers among different histological types of triple-negative breast cancer.

Zhou S, Sun X, Yu L, Zhou R, Li A, Li M, Yang W. Zhou S, et al. Among authors: yang w. J Cancer. 2018 Jan 5;9(3):604-613. doi: 10.7150/jca.19190. eCollection 2018. J Cancer. 2018. PMID: 29483966 Free PMC article.

7

SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.

Li M, Li A, Zhou S, Lv H, Yang W. Li M, et al. Among authors: yang w. J Hematol Oncol. 2019 Feb 8;12(1):14. doi: 10.1186/s13045-019-0700-2. J Hematol Oncol. 2019. PMID: 30736840 Free PMC article.

8

Intense basolateral membrane staining indicates HER2 positivity in invasive micropapillary breast carcinoma.

Zhou S, Yang F, Bai Q, Li A, Li M, Zhong S, Lv H, Shui R, Tu X, Bi R, Xu X, Cheng Y, Yu B, Tang S, Sun X, Zhou X, Yang W. Zhou S, et al. Among authors: yang f, yang w. Mod Pathol. 2020 Jul;33(7):1275-1286. doi: 10.1038/s41379-020-0461-z. Epub 2020 Jan 23. Mod Pathol. 2020. PMID: 31974492 Free article.

9

Impact of the Updated 2018 American Society of Clinical Oncology/College of American Pathologists Guideline for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer.

Li A, Bai Q, Kong H, Zhou S, Lv H, Zhong S, Li M, Bi R, Zhou X, Yang W. Li A, et al. Among authors: yang w. Arch Pathol Lab Med. 2020 Sep 1;144(9):1097-1107. doi: 10.5858/arpa.2019-0369-OA. Arch Pathol Lab Med. 2020. PMID: 32142367 Free article.

10

High frequency of PIK3CA and TERT promoter mutations in fibromatosis-like spindle cell carcinomas.

Zhong S, Zhou S, Li A, Lv H, Li M, Tang S, Xu X, Shui R, Yang W. Zhong S, et al. Among authors: yang w. J Clin Pathol. 2022 Jul;75(7):477-482. doi: 10.1136/jclinpath-2020-207071. Epub 2021 May 5. J Clin Pathol. 2022. PMID: 33952589

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33,699 results

Search Page

Filters